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Background
Cameroon is a country in West Central Africa with a
population of about 20 million inhabitants, with an esti-
mated HIV prevalence of 5.1% in the general population.
The HIV epidemic in this region is marked by a broad
genetic diversity dominated by Circulating Recombinant
Forms (CRFs).
Methods
To characterize HIV-1 genotypes circulating in HIV posi-
tive individuals in Limbe, Cameroon, we phylogenetically
analyzed blood samples from 116 HIV positive patients.
Of 116 samples tested, 110 were amplified by nested PCR
at the Gag, Pol and Env genes. Sequences obtained were
phylogenetically analyzed with reference sequences from
the Los Alamos database. The RT region of samples was
also amplified to identify mutations that conferred resis-
tance to Reverse Transcriptase inhibitors (RTIs) using the
Stanford University Drug resistance database.
Results
Our results revealed a broad genetic diversity, dominated
by circulating recombinant forms as follows: CRF02_AG
50.4% (n=54), CRF22_01A1 7.4% (n=8) F2 3.7% (n=4),
D 2% (n=2), CRF43_02G 2.8% (n=3), CRF18_CPX 2.8%
(n=3) and recombinant forms (RFs) 31.7 %( n=34). Most
RFs contained CRF02_AG in one or two HIV loci ana-
lyzed. RT sequences of 3 patients on HAART and 15
drug naïve individuals harbored mutations which con-
ferred resistance to RTIs.
Conclusion
CRF02_AG continues to be the most predominant strain
in Cameroon, CRF22_01A1 on the increase. Identifica-
tion of drug resistance strains in drug naïve patients
suggest these viruses are being transmitted in the study
population and highlights the need of drug resistance
testing before start of ART for HIV patients.
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